The transition from wellness to digital therapeutics

General wellness apps often face lower valuations because they lack a clinical mission and suffer from high churn. Digital therapeutics (DTx) are different. These tools require rigorous evidence, often involving randomised controlled trials or peer-reviewed studies. If you want to secure a high valuation, you must move beyond lifestyle tracking and toward software that treats, manages, or prevents a specific disease. This transition requires a clear regulatory strategy from day one.

Evidence-based valuations in early-stage health

Your pre-seed or seed valuation depends heavily on clinical milestones. A successful pilot study with a recognised hospital or a 30% increase in patient adherence can significantly de-risk your venture in the eyes of an investor. These proofs of concept are more valuable than a large, unmonetised user base. Understanding how to get vc funding for a health app requires you to treat your product development like a clinical trial. Capital efficiency in healthtech engineering is the strategic prioritisation of technical features that directly accelerate regulatory clearance or clinical validation. Institutional investors look past the interface. A functional MVP in healthtech must prove it can operate within a rigid clinical workflow. If your app does not integrate with existing systems, it will not scale. This technical defensibility is the core of how to get vc funding for a health app in a competitive market. You must move beyond the "wrapper" phase where your app merely sits on top of a generic database. Investors want to see a product that creates a proprietary data loop, where every user interaction improves the underlying model or clinical outcome. Data security is a binary requirement. You either have it or you do not. Founders must demonstrate a clear path toward certifications like ISO 27001 or SOC2 from day one. Institutional capital avoids the liability of unencrypted patient data or weak access controls. Your strategy should include clear protocols for data residency, encryption at rest, and audit trails that satisfy hospital procurement departments. VCs prefer in-house technical leadership. While you might start with external support, your roadmap must show a transition to a dedicated internal team. This ensures the intellectual property remains within the company and allows for rapid iteration based on clinician feedback. Demonstrating this transition is a critical step in learning how to get vc funding for a health app from top-tier firms.

Engineering for healthcare interoperability

Isolation is a product killer. Your technical stack must support HL7 and FHIR standards to ensure seamless data exchange with Electronic Health Records (EHR). Without these integrations, your app becomes another data silo that clinicians will ignore. Dreamoro Studio works with founders to build these complex integrations, ensuring the product is enterprise-ready from the first deployment. We prioritise building systems that talk to the broader ecosystem, turning interoperability into a competitive moat.

Leveraging AI for clinical advantage

AI should drive specific outcomes like faster triage, more accurate diagnostics, or personalised treatment plans. Investors want to see explainable models, not black boxes. You must prove your training data is ethically sourced and high quality. In a sector where a 5% error rate can have life-altering consequences, clinical validation beats marketing hype every time. Focus on transparent models that provide clinicians with the "why" behind every recommendation, ensuring your AI acts as a co-pilot rather than a replacement. If you are currently mapping your technical roadmap, you can review our investment thesis to see how we evaluate AI-enabled healthtech companies. Regulatory compliance is the primary barrier to healthtech commercialisation. It distinguishes a wellness tool from a clinical intervention. For founders, these requirements are not merely red tape; they represent a strategic moat. Investors prioritise teams that treat regulation as a core product feature rather than an afterthought. Early engagement with regulators identifies technical risks before they become terminal for the business. Understanding how to get vc funding for a health app requires a shift in perspective. You are building a regulated medical device, not just a software platform. This distinction dictates your capital requirements and your development timeline. A clear path to clinical validation provides the evidence base required for provider adoption and large-scale procurement. Without it, your software remains a pilot project rather than a scalable health solution.

The TGA and international regulatory standards

The Therapeutic Goods Administration (TGA) is the gatekeeper for the Australian market. Founders must determine if their app qualifies as Software as a Medical Device (SaMD) early in the design phase. While the TGA provides a rigorous framework, global scale requires alignment with the FDA in the United States or CE marking in Europe. Dreamoro's investment thesis focuses on regulatory-aware startups that build for international standards from day one. This foresight reduces the friction of market expansion and increases the valuation at the series A stage.

Establishing a clinical evidence roadmap

Venture capitalists value startups that move beyond anecdotal success. Your roadmap must transition from internal verification to formal clinical trials and, eventually, peer-reviewed publications. Partnerships with research institutions or universities, such as UNSW, provide the intellectual rigour investors expect. These collaborations offer third-party validation that internal data cannot replicate. When preparing for due diligence, maintain a clinical data room that includes: By mapping your clinical evidence to your funding milestones, you demonstrate the disciplined mindset required to lead the next generation of healthcare. This structured approach is essential for any founder learning how to get vc funding for a health app in a market that saw $856M+ invested in Australian healthtech during 2023. Securing capital requires precision. Generalist VCs often focus on user growth and churn; however, healthtech demands a deeper understanding of clinical outcomes and long-tail adoption. Understanding how to get vc funding for a health app means knowing which investors possess the patience for clinical timelines and the expertise to navigate hospital procurement. Specialist funds bring a level of domain expertise that generalists cannot replicate, particularly regarding regulatory hurdles and evidence-based validation.

Finding alignment with a specialist fund

Specialist funds provide value far beyond the initial wire transfer. They offer clinical validation and direct access to healthcare decision-makers. When evaluating a VC, audit their portfolio for synergies. Look for companies that share your target patient demographic or clinical department. This connectivity is a core pillar of the Dreamoro ecosystem, where founders access a network specifically designed to accelerate market entry and clinical adoption.

The healthtech pitch deck structure

Your pitch deck must bridge the gap between clinical efficacy and commercial returns. Focus on how your app integrates into existing healthcare workflows rather than attempting to bypass them. Regulatory and reimbursement slides must be prominent, as these represent the primary risks for investors in this sector. You must demonstrate a clear understanding of who pays for the solution, whether it is an insurer, a hospital, or the patient. The ideal team composition for a healthtech startup includes a clinical lead with domain authority, a technical lead experienced in data security, and a commercial lead who understands the complexities of healthcare procurement. Investors look for this balance to ensure the product is both scientifically sound and market-ready. Showing that your team has navigated these systems previously reduces the perceived execution risk. Due diligence in this sector is data intensive. You should maintain a clean data room that includes HIPAA or GDPR compliance documentation, clinical trial results, and pilot data. Transparency builds the trust necessary for a long-term partnership. Managing this process with rigorous data ensures that lead investors can move from initial interest to a term sheet with confidence. Warm introductions from the broader ecosystem often serve as the catalyst for these high-stakes conversations. If you are building the future of healthcare, learn more about our investment criteria and venture platform. With $856M+ invested in Australian healthtech in 2023, capital is only one component of successful commercialisation. While a capital injection provides runway, it doesn't solve the complex challenges of clinical integration or regulatory compliance. Founders building the future of healthcare need a partner that provides more than just a balance sheet. Understanding how to get vc funding for a health app requires a shift in perspective: you aren't just looking for money, you're looking for an integrated growth engine. Healthtech represents a generational investment theme hiding in plain sight, but capturing that value requires more than passive capital.

The benefits of the venture studio approach

A venture studio model provides hands-on support for engineering and UX/UI design, which is critical for reducing technical debt early in the lifecycle. Managed development operations ensure your product is built on a scalable architecture from day one. This approach allows founders to focus on clinical validation and strategic partnerships rather than managing fragmented freelance teams. Strategic support accelerates the path to your first clinical customers by providing a structured go-to-market framework. Specialist backing through Dreamoro Ventures provides the infrastructure required to scale without the typical friction of early stage development.

Preparing for the journey from pre-seed to Series A

Transitioning from pre-seed to Series A requires meeting specific evidence-based milestones. Investors expect to see a clear regulatory pathway and a defensible strategic position within the broader healthcare ecosystem. Maintaining a clean cap table is essential; complex ownership structures can stall future rounds before they begin. Secure pilot programs with at least two clinical partners to demonstrate real-world utility. This data proves your app isn't just a concept but a functional tool within the healthcare value chain. To understand how to get vc funding for a health app at later stages, you must prove your unit economics are capital-efficient. Dreamoro has mapped 1,005 healthtech companies to identify the specific markers of success in this sector. Operator insights on the Dreamoro blog offer further detail on managing these transitions effectively. Securing capital in 2026 requires more than a polished deck; it demands a product built on clinical evidence and a clear regulatory strategy. Investors now prioritise capital-efficient models that demonstrate a deep understanding of the Australian healthcare ecosystem. With $856M invested in Australian healthtech in 2023, the opportunity remains significant for founders who can prove their product's defensibility through rigorous data and validated outcomes. Understanding how to get vc funding for a health app involves aligning your vision with the specific demands of Medicine 3.0, moving beyond simple wellness features toward integrated platforms that solve systemic inefficiencies. Dreamoro provides the specialised expertise needed to bridge the gap between a prototype and a market-ready medical solution. Our integrated product engineering studio and venture arm work in tandem to accelerate growth. We ensure your technical strategy matches your clinical ambitions by leveraging our deep market intelligence, which includes a comprehensive mapping of 1,005 healthtech companies. Partner with Dreamoro to build the future of healthcare and transform your vision into a disciplined, scalable reality. The path to a generational healthtech company starts with the right strategic foundation.

Do I need clinical trials before seeking VC funding?

You don't need full clinical trials for pre-seed rounds; however, you must present a clear clinical validation roadmap. Investors look for early evidence or pilot data from at least one clinical partner to prove the app's efficacy. In 2023, over $856 million was invested in Australian healthtech, with a heavy preference for evidence-backed solutions. You must demonstrate that your app produces intended health outcomes before committing significant capital.

What is the difference between a health app and a medical device?

The Therapeutic Goods Administration (TGA) determines if a software product is a medical device based on its intended purpose. If your app diagnoses, treats, or prevents a specific condition, it's classified as a medical device under the Therapeutic Goods Act 1989. This classification requires rigorous regulatory oversight and compliance. Understanding these TGA pathways is essential for founders learning how to get vc funding for a health app.

How much equity do healthtech VCs typically take?

Venture capital firms typically seek between 10 and 25 percent equity during a seed round. This range ensures the investor has a meaningful stake while leaving enough founder equity for future rounds. Dreamoro's mapping of 1,005 healthtech companies shows that capital-efficient founders who retain higher ownership through clinical milestones often achieve better long-term outcomes. You should maintain enough equity to ensure your team's motivation through Series A and beyond.

Is AI a requirement for healthtech funding in 2026?

AI isn't a strict requirement for funding in 2026, though it remains a central pillar of the Medicine 3.0 investment theme. Investors prioritise AI that improves diagnostic accuracy by at least 20 percent or significantly enhances operational efficiency. The technology must be transparent, defensible, and clinically sound. We back the founders building the future of healthcare who use AI to solve specific clinical bottlenecks rather than using it as a marketing buzzword.

What are the most common reasons health apps fail to get funding?

Most healthtech startups fail to secure capital because they lack clinical evidence or fail to account for complex reimbursement pathways. A 2024 analysis of failed startups indicates that 42 percent lacked a clear regulatory strategy or failed to integrate with the Medicare Benefits Schedule (MBS). Founders often struggle with how to get vc funding for a health app when their business model ignores the specific procurement cycles of hospitals and private insurers.

How do I protect my intellectual property during the pitch process?

Protect your intellectual property by focusing on high-level strategy and clinical outcomes during the initial pitch. Detailed IP discussions should be reserved for the due diligence phase after a term sheet is signed or a non-disclosure agreement is in place. You shouldn't share source code or specific proprietary algorithms in early meetings. Professional investors respect boundaries around sensitive technology until a formal partnership is established.

Back to BlogARTICLE

How to secure VC funding for a health app: A founder guide

Learn how to get vc funding for a health app with our founder guide. Master clinical validation, regulatory strategy, and pitching to specialist investors.

Klaus Bartosch · 30 March 2026 · 15 min read

Frequently Asked Questions

Klaus Bartosch

CEO, Founder & Managing Partner